- Home
- FRPT vs CLDX Comparison
FRPT vs CLDX Comparison
Compare FRPT & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRPT | CLDX |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.6B |
| IPO Year | 2014 | 1995 |
Fundamental Metrics
Financial Performance| Metric | FRPT | CLDX |
|---|---|---|
| Price | $59.54 | $38.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 10 |
| Target Price | ★ $76.94 | $46.60 |
| AVG Volume (30 Days) | ★ 1.1M | 908.5K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 183.87 | N/A |
| EPS | ★ 0.91 | N/A |
| Revenue | ★ $1,102,015,000.00 | $12,743,000.00 |
| Revenue This Year | $11.34 | $111.39 |
| Revenue Next Year | $9.13 | $235.85 |
| P/E Ratio | $66.64 | ★ N/A |
| Revenue Growth | 13.01 | ★ 87.78 |
| 52 Week Low | $46.45 | $19.72 |
| 52 Week High | $86.00 | $40.30 |
Technical Indicators
Market Signals| Indicator | FRPT | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 58.52 | 57.50 |
| Support Level | $51.54 | $28.51 |
| Resistance Level | $60.78 | $40.30 |
| Average True Range (ATR) | 2.29 | 1.62 |
| MACD | 0.38 | -0.03 |
| Stochastic Oscillator | 71.14 | 70.15 |
Price Performance
Historical ComparisonAbout FRPT Freshpet Inc.
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (likely representing well north of 90% of sales), with cats and treats nascent contributors. Geographically, the company's home US market, where all its food is produced, accounts for nearly all of sales, with exports to Canada, the United Kingdom, and other European countries being very small contributors.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.